+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Hormone Replacement Therapy Market 2020-2026

  • ID: 5148087
  • Report
  • July 2020
  • Region: Global
  • Orion Market Research Private Limited
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Allergan PLC
  • Bristol Myers Squibb Co.
  • Eli Lilly and Co.
  • Merck KGaA
  • Novartis AG
  • MORE
Global Hormone Replacement Therapy Market Size, Share & Trends Analysis Report by Therapy Type (Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement), by Route of Administration (Oral, Parenteral, Other Routes of Administration), by Disease (Menopause, Hypothyroidism, Hypogonadism, Growth Hormone Deficiency, Others), Forecast Period (2020-2026).

The hormone replacement therapy market is anticipated to showcase a considerable CAGR during the forecast period. The rising healthcare expenditure along with the high prevalence of hormone imbalance related disorders such as menopause, hyperthyroid, and growth deficiency is a key factor driving the growth of the global hormone replacement therapy market. However, the lack of proper healthcare infrastructure in the under-developed economies is anticipated to restrain the growth of the global market.

The hormone replacement therapy market is segmented on the basis of therapy type, route of administration, and disease. Based on the therapy type, the hormone replacement therapy market is segmented into estrogen hormone replacement, growth hormone replacement, thyroid hormone replacement, and testosterone replacement. Due to the high adoption of estrogen replacement therapy, it is anticipated to hold considerable market share based on the therapy type. Based on the route of administration, the market is segmented into oral, parenteral, and other routes of administration. Based on disease type, the market is segmented into menopause, hypogonadism, hypothyroidism, growth hormone deficiency, and others.

Geographically, the market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America is anticipated to hold a considerable market share in the hormone replacement therapy market due to the presence of key market players in the region. Asia-Pacific is the fastest-growing region in the hormone replacement therapy market. The increasing prevalence of menopause and female health-related disorders in the emerging economies of Asia-Pacific to drive the growth of the market in the region.

The major players of the hormone replacement therapy market include Abbott Laboratories, Inc. Pfizer Inc., Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Hisamitsu Pharmaceutical Co. Inc., Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, Fuji Pharma Co., Ltd., Cyndea Pharma, Dwarkesh Pharmaceuticals Pvt. Ltd., and so on. These players are actively adopting different growth strategies such as new product launch, partnerships, collaboration, and mergers and acquisition among others to remain competitive in the market place.

Research Methodology:

The market study of the global hormone replacement therapy market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity in the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. Global Hormone Replacement Therapy Market Research and Analysis by Therapy Type
2. Global Hormone Replacement Therapy Market Research and Analysis by Route of Administration
3. Global Hormone Replacement Therapy Market Research and Analysis by Disease Type

The Report Covers:
  • Comprehensive research methodology of the global hormone replacement therapy market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global hormone replacement therapy market.
  • Insights about market determinants which are stimulating the global hormone replacement therapy market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Allergan PLC
  • Bristol Myers Squibb Co.
  • Eli Lilly and Co.
  • Merck KGaA
  • Novartis AG
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Bayer AG
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Abbott Laboratories, Inc.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Novartis AG
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Pfizer, Inc.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Merck KGaA
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments

4. Market Determinants
4.1 Motivators
4.2 Restraints
4.1. Opportunities

5. Market Segmentation
5.1. Global Hormone Replacement Therapy Market by Therapy Type
5.1.1. Estrogen Hormone Replacement
5.1.2. Growth Hormone Replacement
5.1.3. Thyroid Hormone Replacement
5.1.4. Testosterone Replacement
5.2. Global Hormone Replacement Therapy Market by Route of Administration
5.2.1. Oral
5.2.2. Parenteral
5.2.3. Other Routes of Administration
5.3. Global Hormone Replacement Therapy Market by Disease
5.3.1. Menopause
5.3.2. Hypogonadism
5.3.3. Hypothyroidism
5.3.4. Growth Hormone Deficiency
5.3.5. Others

6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. AbbVie, Inc.
7.3. Allergan PLC
7.4. Bayer AG
7.5. Bristol Myers Squibb Co.
7.6. Cyndea Pharma, S.L.
7.7. Dwarkesh Pharmaceuticals Pvt., Ltd.
7.8. Eli Lilly and Co.
7.9. F. Hoffmann-La Roche, Ltd.
7.10. Fuji Pharma Co., Ltd.
7.11. Hisamitsu Pharmaceutical Co., Inc.
7.12. Merck KGaA
7.13. Mylan N.V.
7.14. Novartis AG
7.15. Novo Nordisk A/S
7.16. Pfizer, Inc.
7.17. TherapeuticsMD, Inc.
7.18. Titan Pharmaceuticals, Inc.
Note: Product cover images may vary from those shown
3 of 3
  • Abbott Laboratories, Inc.
  • AbbVie, Inc.
  • Allergan PLC
  • Bayer AG
  • Bristol Myers Squibb Co.
  • Cyndea Pharma, S.L.
  • Dwarkesh Pharmaceuticals Pvt., Ltd.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche, Ltd.
  • Fuji Pharma Co., Ltd.
  • Hisamitsu Pharmaceutical Co., Inc.
  • Merck KGaA
  • Mylan N.V.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • TherapeuticsMD, Inc.
  • Titan Pharmaceuticals, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll